Home › Type 1 Diabetes › Maryland › Baltimore
Type 1 Diabetes clinical trials in Baltimore, MD
6 studies for Type 1 Diabetes are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
Recruiting
- Johns Hopkins Pediatric Diabetes Center, Baltimore
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
RecruitingPhase 1/2
- Barry J. Reiner, MD, LLC, Baltimore
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
Recruiting
- Baltimore VA Medical Center Univ of Maryland, Baltimore
Kidney Precision Medicine Project
RecruitingObservational study
- Johns Hopkins University, Baltimore
Registry for Stage 2 Type 1 Diabetes
RecruitingObservational study
- Johns Hopkins School of Medicine- Site Number : 8400031, Baltimore
The Effects of Fluoxetine and/or DHEA
RecruitingEarly phase 1
- University of Maryland, Baltimore
About Type 1 Diabetes
If the pancreas doesn't make needed insulin, causing blood sugar levels to be too high you have type 1 or juvenile diabetes. Learn the signs.
More about Type 1 Diabetes on MedlinePlus
Type 1 Diabetes trials in other cities
- Aurora, CO23 studies
- Boston, MA21 studies
- Seattle, WA18 studies
- Chicago, IL16 studies
- New York City, NY15 studies
- New Haven, CT15 studies
- Indianapolis, IN14 studies
- San Francisco, CA14 studies
- Miami, FL13 studies
- Gainesville, FL12 studies
- Philadelphia, PA11 studies
- Atlanta, GA11 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Cancer (all types)37 studies
- Colorectal Cancer31 studies
- Pancreatic Cancer31 studies
- Metastatic Cancer28 studies
- Obesity25 studies
- Heart Failure24 studies
- Bladder Cancer24 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.